The University of Manitoba is a Canadian public research university in the province of Manitoba. Founded in 1877, it is the first university of western Canada. Both by total student enrolment and campus area, the U of M is the largest university in the province of Manitoba and the 17th-largest in all of Canada.

During the past decade, University of Manitoba conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 20 clinical trials were completed, i.e. on average, 20.2% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 16 clinical trials were completed. i.e. 35.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Manitoba" #1 sponsor was "University of Manitoba" with 87 trials, followed by "Centers for Disease Control and Prevention" with 14 trials sponsored, "Gilead Sciences" with 9 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored and "University of Calgary" with 4 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Manitoba" #1 collaborator was "University of Manitoba" with 12 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 11 trials as a collaborator, "US Department of Veterans Affairs" with 10 trials as a collaborator, "University of British Columbia" with 6 trials as a collaborator and "University of Toronto" with 4 trials as a collaborator. Other collaborators include 142 different institutions and companies that were collaborators in the rest 126 trials.

According to Clinical.Site data, the most researched conditions in "University of Manitoba" are "Tuberculosis" (11 trials), "Depression" (4 trials), "HIV Infections" (4 trials), "Anxiety" (3 trials) and "Burns" (3 trials). Many other conditions were trialed in "University of Manitoba" in a lesser frequency.

Most popular intervention types in "University of Manitoba" are "Drug" (49 trials), "Other" (41 trials), "Behavioral" (34 trials), "Device" (23 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Rifabutin" (4 trials), "Isoniazid" (3 trials), "Ribavirin" (3 trials) and "Albuferon" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Manitoba" are 160 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 40 active trials in "University of Manitoba". 3 are not yet recruiting, 23 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 97 completed trials in University of Manitoba, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University of Manitoba, 11 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 87 trials that are defined as “Not Applicable".

University of Manitoba has several departments that took part in Clinical trials: "School of Medical Rehabilitation , University of Mantioba" - 8 trials, "The University of Manitoba - Department of Psychology" - 4 trials, "Health Sciences Centre - Diabetes Research Group" - 4 trials, "University of Manitoba Department of Psychiatry" - 2 trials, "College of Pharmacy, University of Manitoba" - 2 trials, "Concordia Joint Replacement Group, Concordia Hip and Knee Institute & University of Manitoba" - 2 trials